Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leathanach 1 ó 809 torthaí
Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
RELATED APPLICATIONS
This application is incorporating by reference Japanese Patent Application No. 7-344947 filed on Dec. 5, 1995, which has the laid open publication (JP09-157236) date of Jun. 17, 1997.
FIELD OF THE INVENTION
The present invention relates to a phenylenediamine derivative and, in
Use of C1-inhibitor for the treatment of secondary edema of the central nervous system
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
STATEMENT REGARDING FEDERAL SPONSORED RESEARCH AND DEVELOPMENT
Not applicable.
BACKGROUND OF THE INVENTION
The subject of the present invention is, in the most general aspect, the prevention and/or treatment of a secondary edema. In particular, the present invention relates to a C1-Inhibitor for use
Vinpocetine for pulmonary hemorrhage and edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION
(a) Field of the Invention
This invention relates to a novel therapeutic use of apovincaminic acid ethyl ester. More specifically this invention relates to a method for inhibiting pulmonary hemorrhage and edema associated with intracranial syndromes such as trauma, tumor,
Cerebral edema solute catheter and method of draining cerebral edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The present invention relates to solute drainage catheters and, in particular, to a catheter for draining interstitial fluid from a cerebral edema.
BACKGROUND OF THE INVENTION
Cerebral edema is a type of brain swelling most commonly associated with cerebral trauma or mass
Cerebral edema solute catheter and method of draining cerebral edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The present invention relates to solute drainage catheters and, in particular, to a catheter for draining interstitial fluid from a cerebral edema.
BACKGROUND OF THE INVENTION
Cerebral edema is a type of brain swelling most commonly associated with cerebral trauma or mass
Systems and methods for monitoring pulmonary edema dynamics
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
TECHNICAL FIELD
This document pertains generally to medical systems, devices, or methods, and more particularly, but not by way of limitation, to systems and methods for monitoring pulmonary edema.
BACKGROUND
One hallmark of heart failure (HF) in a subject is congestion, more commonly referred to as
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND
Surgery has always been a vital part of modern medicine to treat certain conditions that other interventional means cannot. However, surgical procedures are not without some significant complications, such as for example, hematomas, edema, and/or deep vein thrombosis.
Hematomas or blood
Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The invention provides novel polynucleotides and polypeptides associated with the incidence of PPAR-agonist induced edema. The invention also provides polynucleotide fragments corresponding to the genomic and/or coding regions of these polynucleotides which comprise at least
Method and device for treatment of edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
This invention relates to therapeutic compression systems and, in particular, to compression systems for the treatment of edema.
BACKGROUND OF THE INVENTION
The lymphatic system includes lymph vessels, lymph nodes, and lymphoid tissues. Lymphatic fluid, or lymph, is collected
Electromagnetic method of treatment of lesions associated with inadequate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation and infection
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a method for treatment of skin lesions and internal wounds such as viable but underperfused myocardium. More specifically, this invention is related to a method for treatment of a subject afflicted with
Methods for reducing edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND
Certain conditions and diseases of the eye, such as corneal failure, keratoconus, corneal dystrophies, scarring, age related macular degeneration (AMD) and retinitis pigmentosa, have been treated using ocular transplant procedures such as corneal and retinal pigment epithelial (RPE)
Prophylactic and therapeutic methods for treating edema with antamanides
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
GOVERNMENTAL SUPPORT
Research support for the present invention was provided by U.S. Public Health Service NHLB Grants Numbers HL16714 and HL33104.
FIELD OF THE INVENTION
The present invention is concerned with inflammatory and non-inflammatory associated edemas and is particularly directed to
Prophylactic and therapeutic methods for treating interleukin-mediated edemas
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
FIELD OF THE INVENTION
The present invention is concerned with inflammatory and non-inflammatory (hydraulic) associated edemas and is particularly directed to prophylactic and therapeutic methods for treating localized and systemic edemas caused or mediated by interleukins.
BACKGROUND OF THE
Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
Applicant claims priority under 35 U.S.C. .sctn.119 of German Application No. 103 52 692.7 filed Nov. 12, 2003. Applicant also claims priority under 35 U.S.C. .sctn.365 of PCT/EP2004/012363 filed Nov. 2, 2004. The international application under PCT article
Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
This application is a national phase of International Application No. PCT/EP2014/063193 filed Jun. 23, 2014 and published in the English language, which claims priority to Application No. EP 13173446.9 filed Jun. 24, 2013.
FIELD OF THE INVENTION
The present invention relates to pharmaceutically
An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht
- Oibreacha i 55 teanga
- Leigheasanna luibhe le tacaíocht ón eolaíocht
- Aitheantas luibheanna de réir íomhá
- Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
- Léigh foilseacháin eolaíochta a bhaineann le do chuardach
- Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
- Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní
Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe
